n-acetylcysteinamide has been researched along with Disease Models, Animal in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 7 (87.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ercal, N; Karacal, H; Maddirala, Y; Tobwala, S | 1 |
| Baumbusch, LO; Benterud, T; Henckel, E; Løberg, EM; Manueldas, S; Norgren, S; Rivera, S; Saugstad, OD; Solberg, R | 1 |
| Aridon, P; Casari, G; Cittaro, D; De Fusco, M; Fischer, B; Guerrini, R; Lee, WT; Lubarr, N; Lüthy, K; Mackenzie, KM; Mei, D; Meijer, IA; Paesmans, J; Parrini, E; Schoovaerts, N; Swerts, J; Versées, W; Verstreken, P | 1 |
| Goldstein, GA; Pandya, JD; Patel, SP; Pauly, JR; Rabchevsky, AG; Readnower, RD; Sullivan, PG; Yonutas, HM | 1 |
| Eldahan, KC; Goldstein, GA; Magnuson, DS; Morehouse, J; Pandya, JD; Patel, SP; Rabchevsky, AG; Sullivan, PG; VanRooyen, JL; Yonutas, HM | 1 |
| Best, R; Bews, H; Bhindi, R; Chaudhary, R; Cheung, D; Goyal, V; Jassal, DS; Mandal, S; Niraula, S; Premecz, S; Ravandi, A; Shaikh, B; Singal, PK; Thliveris, J | 1 |
| Carlsson, K; Celsi, G; Gong, X; Norgren, S | 1 |
| Atlas, D; Barhum, Y; Benhar, M; Gilgun-Sherki, Y; Grinberg, L; Melamed, E; Offen, D; Reich, R | 1 |
2 trial(s) available for n-acetylcysteinamide and Disease Models, Animal
| Article | Year |
|---|---|
N-acetylcysteine amide confers neuroprotection, improves bioenergetics and behavioral outcome following TBI.
Topics: Acetylcysteine; Aldehydes; Animals; Brain Injuries; Cerebral Cortex; Disease Models, Animal; Double-Blind Method; Energy Metabolism; Glutathione; Male; Maze Learning; Mitochondria; Neuroprotective Agents; Oxidative Stress; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine | 2014 |
N-acetylcysteine amide preserves mitochondrial bioenergetics and improves functional recovery following spinal trauma.
Topics: Acetylcysteine; Animals; Disease Models, Animal; Double-Blind Method; Drug Delivery Systems; Electron Transport Chain Complex Proteins; Energy Metabolism; Female; Ganglia, Spinal; Lameness, Animal; Mitochondria; Motor Activity; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Recovery of Function; Spinal Cord; Spinal Cord Injuries; Synapses; Time Factors | 2014 |
6 other study(ies) available for n-acetylcysteinamide and Disease Models, Animal
| Article | Year |
|---|---|
Prevention and reversal of selenite-induced cataracts by N-acetylcysteine amide in Wistar rats.
Topics: Acetylcysteine; Animals; Blotting, Western; Cataract; Disease Models, Animal; Lens, Crystalline; Male; Ophthalmic Solutions; Oxidative Stress; Rats; Rats, Wistar; Selenious Acid | 2017 |
Cerebellum Susceptibility to Neonatal Asphyxia: Possible Protective Effects of N-Acetylcysteine Amide.
Topics: Acetylcysteine; Animals; Asphyxia Neonatorum; Disease Models, Animal; DNA, Mitochondrial; Humans; Infant, Newborn; Mutation Rate; Neuroprotective Agents; Proteolysis; Purkinje Cells; Swine | 2018 |
TBC1D24-TLDc-related epilepsy exercise-induced dystonia: rescue by antioxidants in a disease model.
Topics: Acetylcysteine; Adolescent; alpha-Tocopherol; Amino Acid Motifs; Amino Acid Sequence; Animals; Animals, Genetically Modified; Antioxidants; Biological Transport; Catalytic Domain; Child; Child, Preschool; Crystallography, X-Ray; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Dystonia; Epilepsy, Rolandic; Female; GTPase-Activating Proteins; Humans; Infant; Locomotion; Male; Models, Molecular; Mutation, Missense; Neurons; Oxidative Stress; Pedigree; Physical Exertion; Protein Conformation; rab GTP-Binding Proteins; Reactive Oxygen Species; Recombinant Proteins; Sequence Alignment; Sequence Deletion; Sequence Homology, Amino Acid; Synaptic Vesicles | 2019 |
The Cardioprotective Role of N-Acetyl Cysteine Amide in the Prevention of Doxorubicin and Trastuzumab-Mediated Cardiac Dysfunction.
Topics: Acetylcysteine; Animals; Antineoplastic Agents; Antioxidants; Cardiotonic Agents; Cardiotoxicity; Disease Models, Animal; Doxorubicin; Drug Monitoring; Echocardiography; Female; Mice; Oxidative Stress; Trastuzumab; Treatment Outcome | 2016 |
Protective effects of N-acetylcysteine amide (NACA) on gentamicin-induced apoptosis in LLC-PK1 cells.
Topics: Acetylcysteine; Acute Kidney Injury; Animals; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Cell Survival; Cells, Cultured; Disease Models, Animal; DNA; Flow Cytometry; Free Radical Scavengers; Gene Expression Regulation; Gentamicins; LLC-PK1 Cells; NF-kappa B; Nitric Oxide Synthase Type II; p38 Mitogen-Activated Protein Kinases; Polymerase Chain Reaction; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Swine | 2012 |
A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis.
Topics: Acetylcysteine; Administration, Oral; Animals; Antimetabolites, Antineoplastic; Biological Transport; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Chelating Agents; Copper; Disease Models, Animal; Drug Evaluation, Preclinical; Encephalomyelitis, Autoimmune, Experimental; Erythrocytes; Female; Humans; JNK Mitogen-Activated Protein Kinases; Matrix Metalloproteinase 9; Mice; Mice, Inbred C3H; Mitogen-Activated Protein Kinases; Molecular Weight; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Sulfhydryl Compounds; Treatment Outcome | 2004 |